FLT3 and acute myeloid leukemia: FMS-like tyrosine kinase 3 (FLT3) is another promising target antigen that could be successfully exploited using FLT3-targeting CAR T-cells demonstrating potent reactivity against AML blasts expressing wild-type or FLT3 with internal tandem duplication (FLT3-ITD) [92].